| Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome I Roberts, M Wright Muelas, JM Taylor, AS Davison, Y Xu, JM Grixti, ... Metabolomics 18 (1), 6, 2022 | 86 | 2022 |
| The RESOLUTE consortium: unlocking SLC transporters for drug discovery G Superti-Furga, D Lackner, T Wiedmer, A Ingles-Prieto, B Barbosa, ... Nature reviews Drug discovery 19 (7), 429-430, 2020 | 72 | 2020 |
| GeneGini: Assessment via the Gini coefficient of reference “housekeeping” genes and diverse human transporter expression profiles S O'Hagan, MW Muelas, PJ Day, E Lundberg, DB Kell Cell systems 6 (2), 230-244. e1, 2018 | 67 | 2018 |
| Rational cell culture optimization enhances experimental reproducibility in cancer cells M Wright Muelas, F Ortega, R Breitling, C Bendtsen, HV Westerhoff Scientific reports 8 (1), 3029, 2018 | 56 | 2018 |
| MassGenie: A transformer-based deep learning method for identifying small molecules from their mass spectra AD Shrivastava, N Swainston, S Samanta, I Roberts, M Wright Muelas, ... Biomolecules 11 (12), 1793, 2021 | 49 | 2021 |
| An overview of cell-based assay platforms for the solute carrier family of transporters V Dvorak, T Wiedmer, A Ingles-Prieto, P Altermatt, H Batoulis, F Bärenz, ... Frontiers in pharmacology 12, 722889, 2021 | 41 | 2021 |
| A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites S Zhang, M Sakuma, GS Deora, CW Levy, A Klausing, C Breda, KD Read, ... Communications biology 2 (1), 271, 2019 | 41 | 2019 |
| The role and robustness of the Gini coefficient as an unbiased tool for the selection of Gini genes for normalising expression profiling data M Wright Muelas, F Mughal, S O’Hagan, PJ Day, DB Kell Scientific reports 9 (1), 17960, 2019 | 38 | 2019 |
| An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines M Wright Muelas, I Roberts, F Mughal, S O’Hagan, PJ Day, DB Kell Metabolomics 16, 1-12, 2020 | 35 | 2020 |
| Harmonizing labeling and analytical strategies to obtain protein turnover rates in intact adult animals DE Hammond, DM Simpson, C Franco, MW Muelas, J Waters, ... Molecular & Cellular Proteomics 21 (7), 2022 | 20 | 2022 |
| The role of drug transporters in phenotypic screening D Kell, MW Muelas, S O'Hagan, P Day | 5 | 2018 |
| Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome. medRxiv. 2020; 2020.12. 09.20246389 I Roberts, MW Muelas, JM Taylor, AS Davison, Y Xu, JM Grixti, N Gotts, ... Google Scholar, 0 | 5 | |
| Quantitative LC–MS study of compounds found predictive of COVID-19 severity and outcome I Roberts, M Wright Muelas, JM Taylor, AS Davison, CL Winder, ... Metabolomics 19 (11), 87, 2023 | 4 | 2023 |
| Novel ‘housekeeping’genes and an unusually heterogeneous distribution of transporter expression profiles in human tissues and cell lines, assessed using the Gini coefficient S O’Hagan, MW Muelas, PJ Day, E Lundberg, DB Kell bioRxiv, 155697, 2017 | 3 | 2017 |
| Deorphanizing solute carriers in Saccharomyces cerevisiae for secondary uptake of xenobiotic compounds I Møller-Hansen, J Sáez-Sáez, SA van der Hoek, JD Dyekjær, ... Frontiers in Microbiology 15, 1376653, 2024 | 1 | 2024 |
| Quantitative LC-MS study of compounds found predictive of COVID-19 severity and outcome (preprint) I Roberts, MW Muelas, JM Taylor, AS Davison, CL Winder, R Goodacre, ... | | 2023 |
| Understanding the Metabolomics of Uveal Melanoma M Matareed, C Figueiredo, H Muhamadali, R Goodacre, MW Muelas, ... JOURNAL OF PATHOLOGY 255, S54-S54, 2021 | | 2021 |
| An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters. Front. Pharmacol. 12: 722889. doi: 10.3389/fphar. 2021.722889 V Dvorak, T Wiedmer, A Ingles-Prieto, P Altermatt, H Batoulis, F Bärenz, ... Frontiers in Pharmacology| www. frontiersin. org 12, 2021 | | 2021 |
| Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.(preprint) I Roberts, MW Muelas, JM Taylor, AS Davison, Y Xu, JM Grixti, N Gotts, ... | | 2020 |
| A Systems Biology Approach to Cancer Metabolism MW Muelas PQDT-UK & Ireland, 2016 | | 2016 |
Douglas KellUniversity of LiverpoolVerified email at liv.ac.uk
